BioCentury
ARTICLE | Finance

Ebb & Flow

July 21, 2003 7:00 AM UTC

While bankers wait for the IPO levy to break, they remain busy stuffing follow-on paper into the queue. Including the deal filed by Esperion (ESPR) after market on the prior Friday, three significantly sized deals were proposed over the last week. If sold at Friday’s closing prices, the group would raise $181.3 million.

Cardiovascular company ESPR enlisted Lehman; Citigroup; Needham; and Piper to sell 4 million shares, which would raise $78.4 million at Friday’s close of $19.60. In addition, functional genomics play Lexicon (LEXG) would raise $64.1 million via its 10 million share deal through Morgan Stanley; UBS; Piper; and Punk Ziegel. And cancer play Onyx (ONXX) would raise $58.6 million through its 4 million share offering through Morgan Stanley; Lehman; and SG Cowen. ...